TOKYO -- Japan's Mitsubishi Chemical Group has taken steps toward selling subsidiary Mitsubishi Tanabe Pharma, rethinking its position in the R&D-intensive pharmaceutical sector to free up funds for its slumping chemical business.
Pharmaceuticals
Japan's Mitsubishi Chemical weighs sale of pharmaceutical unit
R&D costs put Mitsubishi Tanabe on chopping block in push to boost profitability
Mitsubishi Chemical is considering selling its pharmaceutical unit to focus resources on its mainstay chemicals. (Photo by Yumi Kotani)
Read Next
Latest on Pharmaceuticals
